Taisho Of Japan Joins Move To Off-Peak Power During Disasters
This article was originally published in PharmAsia News
Executive SummaryJapan's Taisho Pharmaceutical has resumed weekend production at two of its plants despite the nation's limited electric power resulting from its triple disaster
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.